Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Last revisionBoth sides next revision
home:publications:marshall_theoretical_2006 [03.08.2019] – [Conclusion] sallieqhome:publications:marshall_theoretical_2006 [03.08.2019] – [Paper - Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b] sallieq
Line 12: Line 12:
 \\ \\
 **See also:** [[http://www.tbiomed.com/content/3/1/1|full text]]; [[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360063|PubMed Central record]] **See also:** [[http://www.tbiomed.com/content/3/1/1|full text]]; [[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360063|PubMed Central record]]
 +
 +//And see// **Editor's note** //below//
  
  
Line 33: Line 35:
 ==== Editor's note ==== ==== Editor's note ====
  
-Professor Marshall now says+(//since 2008//)  Professor Marshall now says
 <blockquote>I am certain that the primary mode of action of Olmesartan is agonism of the human VDR, and the subsequent reconditioning of the human immune system. <blockquote>I am certain that the primary mode of action of Olmesartan is agonism of the human VDR, and the subsequent reconditioning of the human immune system.
  
home/publications/marshall_theoretical_2006.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.